| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,745 |
8,187 |
$384K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
681 |
660 |
$33K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
657 |
614 |
$31K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,172 |
1,135 |
$26K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
724 |
712 |
$24K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
253 |
242 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
742 |
712 |
$5K |
| 87081 |
|
398 |
385 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
28 |
26 |
$530.15 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
23 |
12 |
$388.24 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
12 |
$130.60 |
| 90686 |
|
28 |
26 |
$0.00 |